FDA Regulatory Framework Overview

Learning Outcomes

• Describe the three main FDA premarket pathways (510(k), PMA, De Novo)
• Compare FDA and MDR classification systems and identify where they diverge
• Identify key differences in clinical evidence and quality system requirements between EU and US